Neurology Today in 5

Mar 19 2025 99 ep. 5 mins 1.9k
Neurology Today in 5 Podcast artwork

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

  Health & Fitness
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Impact of NIH cuts on neurology research, response to ACP’s guideline on migraine, an updated position on seizures, driver licensure, and medical reporting

Mar 19 2025 5 mins  
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting.

Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists

Mar 05 2025 4 mins  
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled program that detects hidden features in EEGs for epilepsy detection, and neurology-trained pharmacists who are working with neurology departments.

IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function.

Feb 19 2025 5 mins  
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associated with loneliness, social isolation and brain function, and the role of community-based neurologists in drug development.

Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

Feb 05 2025 4 mins  
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.

Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.

Jan 15 2025 4 mins  
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors’ picks for the best advances of 2024.

Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.

Jan 01 2025 4 mins  
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.

Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty

Dec 18 2024 5 mins  
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.

3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration

Dec 04 2024 5 mins  
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathwa

Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s

Nov 20 2024 4 mins  
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer’s disease.

Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression

Nov 06 2024 4 mins  
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson’s, and the role of cholesterol overload in ALS progression and disease risk.